GrippeAllemagneV3, Main, Exploration, bibRecord, 000377

[Community-acquired pneumonia].

Identifieur interne : 000377 ( Main/Exploration ); précédent : 000376; suivant : 000378

[Community-acquired pneumonia].

Auteurs : T. Welte [Allemagne]

Source :

Der Internist [ 1432-1289 ] ; 2009.

RBID : pubmed:19156393

Descripteurs français

KwdFr :
- Allemagne (épidémiologie), Antibactériens (usage thérapeutique), Facteurs de risque, Humains, Incidence, Infection croisée (), Infection croisée (diagnostic), Infection croisée (épidémiologie), Pneumopathie bactérienne (), Pneumopathie bactérienne (diagnostic), Pneumopathie bactérienne (épidémiologie), Évaluation des risques ().
MESH :
- diagnostic : Infection croisée, Pneumopathie bactérienne.
- usage thérapeutique : Antibactériens.
- épidémiologie : Allemagne, Infection croisée, Pneumopathie bactérienne.
- Facteurs de risque, Humains, Incidence, Infection croisée, Pneumopathie bactérienne, Évaluation des risques.
Wicri :
- geographic : Allemagne.

English descriptors

KwdEn :
- Anti-Bacterial Agents (therapeutic use), Cross Infection (diagnosis), Cross Infection (epidemiology), Cross Infection (prevention & control), Germany (epidemiology), Humans, Incidence, Pneumonia, Bacterial (diagnosis), Pneumonia, Bacterial (epidemiology), Pneumonia, Bacterial (prevention & control), Risk Assessment (methods), Risk Factors.
MESH :
- chemical , therapeutic use : Anti-Bacterial Agents.
- geographic , epidemiology : Germany.
- diagnosis : Cross Infection, Pneumonia, Bacterial.
- epidemiology : Cross Infection, Pneumonia, Bacterial.
- methods : Risk Assessment.
- prevention & control : Cross Infection, Pneumonia, Bacterial.
- Humans, Incidence, Risk Factors.

Abstract

Community-acquired pneumonia is the most common cause of death amongst all infectious diseases in the world. Mortality is low in patients treated as outpatients (<1%), but significantly raised (close to 14% in Germany) in hospital admitted patients. Especially at risk are patients from nursing homes, and patients with co-morbidities (chronic heart failure, chronic liver disease, neurological disease). Appropriate initial antibiotic therapy is the key factor in influencing patient outcome. Today, a risk stratification approach is used for initiating antibiotic therapy. Low risk patients can be treated as outpatients with a narrow spectrum beta-lactam for 5 days. With an increasing number of risk factors hospital admittance is recommended and broader spectrum antibiotics providing additional cover for atypical pathogens are required. Influenza and pneumococcal vaccination are proven to reduce the number and the severity of CAP cases significantly. The recommendations of the Ständige Impfkommission (Stiko) in Germany therefore warrant implementation in daily practice.

DOI: 10.1007/s00108-008-2294-6
PubMed: 19156393

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000425
to stream Main, to step Curation: 000425

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Community-acquired pneumonia].</title>
<author><name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name>
<affiliation wicri:level="3"><nlm:affiliation>Abteilung Pneumologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland. welte.tobias@mh-hannover.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Abteilung Pneumologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover</wicri:regionArea>
<placeName><region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Hanovre</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19156393</idno>
<idno type="pmid">19156393</idno>
<idno type="doi">10.1007/s00108-008-2294-6</idno>
<idno type="wicri:Area/Main/Corpus">000425</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000425</idno>
<idno type="wicri:Area/Main/Curation">000425</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000425</idno>
<idno type="wicri:Area/Main/Exploration">000425</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Community-acquired pneumonia].</title>
<author><name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name>
<affiliation wicri:level="3"><nlm:affiliation>Abteilung Pneumologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland. welte.tobias@mh-hannover.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Abteilung Pneumologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover</wicri:regionArea>
<placeName><region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Hanovre</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Der Internist</title>
<idno type="eISSN">1432-1289</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Cross Infection (diagnosis)</term>
<term>Cross Infection (epidemiology)</term>
<term>Cross Infection (prevention & control)</term>
<term>Germany (epidemiology)</term>
<term>Humans</term>
<term>Incidence</term>
<term>Pneumonia, Bacterial (diagnosis)</term>
<term>Pneumonia, Bacterial (epidemiology)</term>
<term>Pneumonia, Bacterial (prevention & control)</term>
<term>Risk Assessment (methods)</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Allemagne (épidémiologie)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Incidence</term>
<term>Infection croisée ()</term>
<term>Infection croisée (diagnostic)</term>
<term>Infection croisée (épidémiologie)</term>
<term>Pneumopathie bactérienne ()</term>
<term>Pneumopathie bactérienne (diagnostic)</term>
<term>Pneumopathie bactérienne (épidémiologie)</term>
<term>Évaluation des risques ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infection croisée</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Risk Assessment</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term>
<term>Infection croisée</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Incidence</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term>
<term>Humains</term>
<term>Incidence</term>
<term>Infection croisée</term>
<term>Pneumopathie bactérienne</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Community-acquired pneumonia is the most common cause of death amongst all infectious diseases in the world. Mortality is low in patients treated as outpatients (<1%), but significantly raised (close to 14% in Germany) in hospital admitted patients. Especially at risk are patients from nursing homes, and patients with co-morbidities (chronic heart failure, chronic liver disease, neurological disease). Appropriate initial antibiotic therapy is the key factor in influencing patient outcome. Today, a risk stratification approach is used for initiating antibiotic therapy. Low risk patients can be treated as outpatients with a narrow spectrum beta-lactam for 5 days. With an increasing number of risk factors hospital admittance is recommended and broader spectrum antibiotics providing additional cover for atypical pathogens are required. Influenza and pneumococcal vaccination are proven to reduce the number and the severity of CAP cases significantly. The recommendations of the Ständige Impfkommission (Stiko) in Germany therefore warrant implementation in daily practice.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19156393</PMID>
<DateCompleted><Year>2009</Year>
<Month>06</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-1289</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>50</Volume>
<Issue>3</Issue>
<PubDate><Year>2009</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Der Internist</Title>
<ISOAbbreviation>Internist (Berl)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Community-acquired pneumonia].</ArticleTitle>
<Pagination><MedlinePgn>331-9; quiz 340</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00108-008-2294-6</ELocationID>
<Abstract><AbstractText>Community-acquired pneumonia is the most common cause of death amongst all infectious diseases in the world. Mortality is low in patients treated as outpatients (<1%), but significantly raised (close to 14% in Germany) in hospital admitted patients. Especially at risk are patients from nursing homes, and patients with co-morbidities (chronic heart failure, chronic liver disease, neurological disease). Appropriate initial antibiotic therapy is the key factor in influencing patient outcome. Today, a risk stratification approach is used for initiating antibiotic therapy. Low risk patients can be treated as outpatients with a narrow spectrum beta-lactam for 5 days. With an increasing number of risk factors hospital admittance is recommended and broader spectrum antibiotics providing additional cover for atypical pathogens are required. Influenza and pneumococcal vaccination are proven to reduce the number and the severity of CAP cases significantly. The recommendations of the Ständige Impfkommission (Stiko) in Germany therefore warrant implementation in daily practice.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Welte</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Abteilung Pneumologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland. welte.tobias@mh-hannover.de</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Ambulant erworbene Pneumonie.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Internist (Berl)</MedlineTA>
<NlmUniqueID>0264620</NlmUniqueID>
<ISSNLinking>0020-9554</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>30</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>6</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19156393</ArticleId>
<ArticleId IdType="doi">10.1007/s00108-008-2294-6</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2008 May 15;46(10):1499-509</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18419482</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2003 Jul 15;37(2):230-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12856216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 2004 Apr;125(4):1343-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15078744</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2004 May 15;38 Suppl 4:S357-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15127370</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2008 Aug;63(8):698-702</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18492742</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2008 Apr 1;46(7):1015-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18444818</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2005 Aug;60(8):672-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16061709</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2003 Sep 15;37(6):752-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12955634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2006 Jul 1;174(1):84-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16603606</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 1;348(18):1737-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12724479</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2008 Feb;31(2):349-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17959641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17278083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Klin (Munich). 2006 Apr 15;101(4):313-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16607488</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pneumologie. 2005 Sep;59(9):612-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16170727</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2006 Dec 9;333(7580):1193</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17090560</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2004 Aug 15;170(4):440-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15184200</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2008 Sep;32(3):199-206</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18378430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2008 Jul;32(1):139-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18287129</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2005 Dec 15;41(12):1697-705</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16288390</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2007 Sep;55(3):233-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17599417</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infection. 2004 Aug;32(4):234-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15293080</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2006 Aug 15;43(4):432-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16838231</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2003 May;58(5):377-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12728155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2006 Jun 10;332(7554):1355</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16763247</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Intern Med. 2007 Jan 8;167(1):53-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17210878</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2005 Mar 5-11;365(9462):855-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15752529</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Intern Med. 2006 Jul;260(1):93-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16789984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1997 Jan 23;336(4):243-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8995086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 1995 Oct 1;123(7):518-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7661497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Basse-Saxe</li>
</region>
<settlement><li>Hanovre</li>
</settlement>
</list>
<tree><country name="Allemagne"><region name="Basse-Saxe"><name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000377 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000377 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeAllemagneV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:19156393
   |texte=   [Community-acquired pneumonia].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:19156393" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020

	Corpus GrippeAllemagneV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeAllemagneV3

[Community-acquired pneumonia].

[Community-acquired pneumonia].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki